TradeTrade
Jump to any asset 873 assets, updated daily

Head-to-head · Stock vs Stock

Eli Lilly & Co vs AbbVie

Stock·NYSE

Eli Lilly & Co LLY

$1,279.14 ▲ 0.45%
Buy
78 / 100 AI score
Full LLY analysis →
vs

Stock·NYSE

AbbVie Inc. ABBV

$286.39 ▼ 0.12%
Buy
72 / 100 AI score
Full ABBV analysis →
01

LLY vs ABBV: the verdict

How LLY and ABBV compare today, and what CleaRank Financial AI makes of it.

The verdict

CleaRank Financial AI favours LLY
LLY ABBV
78/100 AI score 72/100
+55.0% 1-year change +25.6%
29.7% Volatility (30d, yearly) 21.7%
63.0 RSI (14-day) 65.5
42.9x P/E ratio 80.9x
0.52% Dividend yield 2.42%
The verdict
Eli Lilly & Co (LLY) comes out ahead on CleaRank's model, scoring 78/100 (Buy) against 72/100 (Buy) for AbbVie (ABBV). The widest gap is revenue growth: for LLY, revenue grew 47.67%, 39.6 percentage points faster than the sector median.
Key difference
LLY also comes out ahead on profitability. Its net margin is 33.53%, and its return on equity of 102.29% sits above the sector median.
Outlook
LLY's uptrend holds while it stays above its 50-day average at $1,188.58 and its 200-day at $1,085.91. ABBV's uptrend holds while it stays above its 50-day average at $266.87 and its 200-day at $235.72.
02

Price, side by side

Both prices start at 0% on the first day of the period you pick, so the moves compare directly.

Rebased price

Nov '25Jan '26Mar '26Jun '26Aug '26Oct '26
LLY ABBV

Over 1 year: LLY gained 55.0% and ABBV gained 25.8%, a gap of 29.2 points in LLY's favour.

03

Valuation and profitability

What each costs relative to its earnings and sales, and how much of its revenue it keeps.

Side by side

Valuation

Lower multiples mean you pay less for each dollar of earnings or sales.

LLY ABBV
$1.14T Market cap $506.1B
42.9x P/E ratio 80.9x
14.3x Price / sales 7.9x
33.7x Price / book N/A
28.3x EV / EBITDA 18.5x

Profitability

How much of each dollar of revenue becomes profit, and how hard the capital works.

LLY ABBV
+47.7% Revenue growth (quarter, y/y) +10.2%
33.5% Net margin 9.7%
102.3% Return on equity N/A
20.4% Return on assets 10.5%
1.62 Debt / equity -0.12
On valuation
ABBV has the higher trailing P/E, at 81.00 compared with 42.95 for LLY. Both P/Es sit at a premium to peers, when the Healthcare median is 31.9. LLY is valued higher on sales, at 14.32 times against 7.91. LLY is also the larger company, with a market value of $1.14T to $506.7B.
On profitability
LLY turns more of each sale into profit, with a net margin of 33.53% compared with 9.80% for ABBV. Year on year, in the latest quarter, LLY's revenue grew 47.67%, while ABBV's grew 10.16%. On income, LLY's trailing dividend yield is 0.52% and ABBV's is 2.41%.

Earnings reality check

LLY

LLY beat the estimate in 6 of its last 7 reports (latest Aug '26); the shares fell the next session after 2 of those beats.

Surprise
Next session
Feb '25Aug '25Feb '26Aug '26

ABBV

ABBV beat the estimate in 4 of its last 4 reports (latest Jul '26); the shares fell the next session after 2 of those beats.

Surprise
Next session
Jul '25Oct '25Feb '26Jul '26
04

Momentum and sentiment

The indicators behind each AI score, side by side.

Indicators side by side

LLY ABBV
78/100 AI score 72/100
63.0 RSI (14-day) 65.5
+7.6% Price against 50-day average +7.0%
+17.8% Price against 200-day average +21.3%
Technicals
LLY is in an uptrend, trading 7.62% above its 50-day average and 17.79% above its 200-day average. Its 14-day RSI is 63.0, in the bullish zone, with the MACD line positive. ABBV is in an uptrend, trading 7.03% above its 50-day average and 21.33% above its 200-day average. Its 14-day RSI is 66.2, in the bullish zone, with the MACD line positive. ABBV sits higher in its 52-week range, at 95% against 92% for LLY.
Sentiment
Of the 31 analysts covering LLY, 26 rate it buy, 3 hold and 2 sell; their median target is $1,380.50, 7.9% above the price. Of the 30 analysts covering ABBV, 24 rate it buy, 5 hold and 1 sell; their median target is $286.50, 0.1% below the price.
05

Risk and practical tips

How much each moves, how much return each has paid for that risk, and what to watch if you hold either.

Risk measures

LLY ABBV
29.7% Volatility (30d, yearly) 21.7%
0.45 Beta against the S&P 500 0.23
0.47 Sharpe ratio 0.61
Risk
LLY moves more on an average day, 1.70% against 1.13% for ABBV. Against the S&P 500, LLY has a beta of 0.45 and ABBV 0.23. Their worst falls in the price history were 32.3% for LLY (August 2024 to August 2025) and 43.5% for ABBV (January 2018 to August 2019). The measures split: LLY moves more on an average day and has the higher beta, while ABBV has had the deeper worst fall.
ProTips
  1. For LLY, watch the 52-week high at $1,321.21 above the price and the 20-day EMA at $1,227.05 below it.
  2. For ABBV, watch the 52-week high at $291.40 above the price and the 20-day EMA at $278.18 below it.
06

LLY vs ABBV: long-term scenarios

Simulated paths from each price history. A range of outcomes, not a forecast.

Simulated growth of $10,000

202620282030203220342036
LLY median LLY 90th ABBV median ABBV 90th
LLY ABBV
$8,619 Downside, 2036 (10th) $8,767
$29,639 Base case, 2036 (median) $25,402
$101,917 Upside, 2036 (90th) $73,602

In the median simulated path, $10,000 in LLY grows to about $29,600 and $10,000 in ABBV to about $25,400 by 2036. The paths come from each asset's own historical volatility and trend; they are statistical outcomes, not forecasts.

07

Trade plans for both

Entry, stop and target levels from each moving average and its volatility. Educational, not advice.

Actionable Trade Plans

Select Your Trade Bias
Risk Tolerance
Conservative 3% Aggressive
Portfolio Value
$ ✎
Position Size: $200 - $300 per asset
LLY
Current: $1,279.14
ENTRY ZONES
$1,215.18
$1,279.14
RISK MANAGEMENT
STOP LOSS
$1,178.73
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5% from current
$1,343.10
+10% from current
$1,407.05
+15% from current
$1,471.01
ABBV
Current: $286.39
ENTRY ZONES
$272.07
$286.39
RISK MANAGEMENT
STOP LOSS
$263.91
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5% from current
$300.71
+10% from current
$315.03
+15% from current
$329.35
Disclaimer
The content is for educational purposes only. The verdict weighs trend, valuation and risk together. Trading involves risk of loss.

Note: The AI favored LLY based on growth trajectory, on today's data.
08

LLY vs ABBV: questions people ask

Answered from the figures on this page.

Frequently Asked Questions

Which is better, LLY or ABBV?+
On CleaRank's model LLY scores higher, 78/100 (Buy) against 72/100 (Buy) for ABBV. This describes the data on this page and is not a personal recommendation.
Which has performed better over the past year, LLY or ABBV?+
Over the past year LLY has done better. Its price rose 54.96%, while ABBV's rose 25.77%.
Which is cheaper on earnings, LLY or ABBV?+
LLY has the lower trailing P/E, at 42.95 against 81.00 for ABBV.
Which pays more income, LLY or ABBV?+
ABBV pays the higher yield, 2.41% against 0.52% for LLY. Yield is the payout divided by the price, so it moves whenever either of those does.
Which is riskier, LLY or ABBV?+
Most of the measures we track point to LLY as the riskier of the two. Average daily move: 1.70% for LLY, 1.13% for ABBV. Beta against the S&P 500: 0.45 for LLY, 0.23 for ABBV. Worst fall in the price history: 32.3% for LLY, 43.5% for ABBV.
Which has stronger momentum right now, LLY or ABBV?+
ABBV has the higher 14-day RSI, 66.2 (bullish) against 63.0 (bullish) for LLY. Both MACD lines are positive. Readings above 70 or below 30 mark stretched momentum.
Which is the bigger company, LLY or ABBV?+
LLY is the larger company. Its market value is $1.14T, while ABBV's is $506.7B.
What do analysts say about LLY and ABBV?+
LLY has 26 buy ratings out of 31, and its median target sits 7.9% above the price. ABBV has 24 buy ratings out of 30, and its median target sits 0.1% below the price.
How would $10,000 have grown in LLY or ABBV?+
Invested in October 2016, $10,000 would be worth $196,258 today in LLY and $69,945 in ABBV.

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. This AI-generated comparison of LLY vs ABBV is for educational and informational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities or digital assets. The comparison metrics, trade plans, and AI signals are hypothetical, hindsight-based, and simulated. Different asset classes carry different risk profiles - stocks, ETFs, cryptocurrencies, commodities, and forex each have unique regulatory frameworks and risk factors. Market data is provided "as-is" and may be delayed by 15 minutes or more. Past performance does not guarantee future results. You should never invest money you cannot afford to lose. Consult a qualified financial advisor before making any investment decisions. Analysis generated on October 28, 2026.

Disclaimer:

Engaging in financial markets carries significant risk of total capital loss. Markets are volatile, unpredictable, and past success does not guarantee future results. Never invest funds you cannot afford to lose. CleaRank does not offer financial, investment, or advisory services. We provide no recommendations, endorsements, or guarantees regarding market outcomes. You alone are responsible for your decisions.

Advertiser Disclosure:

At CleaRank, clarity and transparency are more than ideals, they are the core of our operations. CleaRank is a paid SaaS platform: the Pro and Ultra workbench plans are paid subscriptions, while everything else on this site, including our trading calculators, tools and market news, is free to use. In the spirit of full disclosure: some of our free editorial content contains partner links, and we may earn affiliate commissions from them. This never affects what you pay. Please keep in mind that your confidence in our platform is what matters to us most and we are devoted to earning your trust every day through consistent transparency. CleaRank's Editorial team works independently from partner relationships and financial incentives. All material and information made available by CleaRank stem from our unique technology and methodology which are created to prioritize your needs as a trader and deliver actionable insights to help you make clearer decisions.